Middle East & Africa Connective Tissue Disease Market Size & Outlook
The connective tissue disease market in Middle East & Africa is expected to reach a projected revenue of US$ 1,159.7 million by 2030. A compound annual growth rate of 4.4% is expected of Middle East & Africa connective tissue disease market from 2024 to 2030.
Revenue, 2023 (US$M)
$856.2
Forecast, 2030 (US$M)
$1,159.7
CAGR, 2024 - 2030
4.4%
Report Coverage
Middle East & Africa
Middle East & Africa connective tissue disease market, 2018-2030 (US$M)
MEA connective tissue disease market highlights
- The MEA connective tissue disease market generated a revenue of USD 856.2 million in 2023.
- The market is expected to grow at a CAGR of 4.4% from 2024 to 2030.
- In terms of segment, rheumatoid arthritis (ra) was the largest revenue generating disease in 2023.
- Rheumatoid Arthritis (RA) is the most lucrative disease segment registering the fastest growth during the forecast period.
MEA data book summary
| Market revenue in 2023 | USD 856.2 million |
| Market revenue in 2030 | USD 1,159.7 million |
| Growth rate | 4.4% (CAGR from 2023 to 2030) |
| Largest segment | Rheumatoid arthritis (ra) |
| Fastest growing segment | Rheumatoid Arthritis (RA) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Rheumatoid Arthritis (RA) |
| Key market players worldwide | AbbVie Inc, Boehringer Ingelheim Pharma, Novartis AG ADR, Regeneron Pharmaceuticals Inc, Pfizer Inc, Bristol-Myers Squibb Co, Roche Holding AG, UCB SA, Johnson & Johnson, Amgen Inc, Eli Lilly and Co |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.6% of the global connective tissue disease market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 8,760.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Connective Tissue Disease Market Scope
Connective tissue disease market segmentation & scope
Systemic Lupus Erythematosus (SLE)
Scleroderma
Polymyositis
Dermatomyositis
Sjogren's Syndrome
Mixed Connective Tissue Disease (MCTD)
Undifferentiated Connective Tissue Disease (UCTD)
Other connective tissue diseases
Drug
Biopharmaceuticals
Biologics
TNF-alpha antagonists
T-cell inhibitors
CD20 antigen
JAK inhibitors
anti-IL6 biologics
Biosimilars
Pharmaceuticals
NSAIDs
Analgesics
DMARDs
Glucocorticoids
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Connective Tissue Disease Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa connective tissue disease market
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
